Cargando…
Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach
BACKGROUND: Infection by any one of 15 high risk human papillomavirus (hrHPV) types causes most invasive cervical cancers. Their oncogenic genome is encapsidated by L1 (major) and L2 (minor) coat proteins. Current HPV prophylactic vaccines are composed of L1 virus-like particles (VLP) that elicit ty...
Autores principales: | Wu, Wai-Hong, Alkutkar, Tanwee, Karanam, Balasubramanyan, Roden, Richard BS, Ketner, Gary, Ibeanu, Okechukwu A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566294/ https://www.ncbi.nlm.nih.gov/pubmed/26362430 http://dx.doi.org/10.1186/s12985-015-0364-7 |
Ejemplares similares
-
Hydropathic characteristics of adenovirus hexons
por: Li, Q.-G., et al.
Publicado: (1997) -
Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo
por: Tian, Jie, et al.
Publicado: (2022) -
Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination
por: Yang, Benjamin, et al.
Publicado: (2015) -
Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46
por: Persson, B. David, et al.
Publicado: (2021) -
Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion
por: Hansra, Satyender, et al.
Publicado: (2015)